G4S carve-out lacks compelling valuation bump 9 Aug 2019 The British security firm is spinning off its cash-handling unit, a no-brainer given the shift to digital money. That allows more focus on its core business of guarding people and businesses. But a share price bump requires investors to place a high value on the latter.
Healthineers robot buy puts big price on old veins 8 Aug 2019 The $41 bln Siemens spinoff is paying $1.1 bln for Corindus, which helps automate vascular operations. It’s paying a vein-popping 100 times revenue to stay ahead of Philips in the race to fix ageing blood vessels. Healthineers will have to pump up growth to justify the price.
Bolloré hits right note to mute Vivendi doubters 6 Aug 2019 The French tycoon may sell 10% of Universal to China’s Tencent at a price that values the music label at 30 billion euros. Sceptics who feared a deal wouldn’t happen this year will be silenced. But more selloffs are required to erase Vivendi’s persistent conglomerate discount.
Indian mogul’s ode to Anglo ends on duff note 26 Jul 2019 Anil Agarwal is dumping his roughly 20% stake in miner Anglo American. The complex holding structure, dubbed “poems” by creator JPMorgan, meant he only partly profited as the target’s shares soared. The bigger prize, meshing it with his Vedanta empire, also proved elusive.
WPP disposal offers cautionary tale for Publicis 2 Jul 2019 The UK ad group is selling the debris from a debt-driven acquisition spree under former boss Martin Sorrell. Its $12.3 bln French rival is borrowing to splurge on a data business. Publicis’ lowly valuation shows investors fear that CEO Arthur Sadoun may repeat Sorrell’s mistakes.
John Malone’s M&A nous gets short shrift in Europe 28 Jun 2019 The cable cowboy’s Liberty Global should get $15 bln of cash from Swiss and German asset sales. A lowly share price means investors are worried Malone will waste the money. That’s unmerited: share buybacks and further selloffs seem likelier than a risky acquisition.
Casino takes baby step on road to redemption 28 Jun 2019 The French grocer has simplified its Latin American structure. The bankruptcy of Casino’s parent company Rallye frees it to recapture some value for investors, and offloading stakes in Latam supermarkets would cut leverage. A focused French business could be an easier sell.
Greyhound activist gets few scraps from board coup 25 Jun 2019 Coast Capital failed in its move to revamp the board of FirstGroup, UK owner of the bus operator. True, Chairman Wolfhart Hauser won’t stand for re-election. But the board is mostly unchanged. And, having defeated one revolt, FirstGroup may take longer to break itself up.
Bristol-Myers drug sale tests $74 bln Celgene deal 24 Jun 2019 U.S. trustbusters have butted in once again, forcing the divestiture of a lucrative treatment. Bristol-Myers could have off-loaded its own nascent drug. Instead it may be hoping for a big price. That would support the idea that Celgene was undervalued, but it’s a riskier path.
VW $17 bln IPO gets reform drive back on the road 14 Jun 2019 The German carmaker is offering a smaller slice of its truck unit at a lower valuation, after delaying the float in March. It’s a sign that CEO Herbert Diess wants to simplify the group even if proceeds are less than hoped. That’s encouraging for VW’s often-ignored investors.
Anbang’s Dutch cast-off hopes for third time lucky 10 Jun 2019 Apollo-backed Athora is paying the defunct Chinese group 2.5 bln euros for insurer Vivat, its third owner in five years. The sale spares the blushes of the Dutch regulator for approving the previous sale. The new Bermuda-based owner is not risk-free but looks relatively safer.
Bayer animal-health buyout will need heavy petting 3 Jun 2019 Private equity groups are itching to get their hands on the German group’s flea-powder and tick-collar unit, the FT says. To earn a decent return, a new owner would need to supercharge sales, boost margins and cut R&D. Even then, the mooted 8 bln euro price tag looks excessive.
Chevron’s North Sea deal eases its wounded pride 30 May 2019 The U.S. oil major has sold its assets off the British coast for $2 bln, at a better valuation than recent deals have fetched. Buyer Ithaca should still make a decent return. Chevron shows it hasn’t completely lost its dealmaking nous after being jilted at the altar by Anadarko.
Greyhound sale is first leg of owner’s long trip 30 May 2019 Under pressure from an activist, Britain’s FirstGroup is selling the iconic U.S. coach group and spinning off its UK bus unit. Simplifying the $1.8 bln group should unlock value. But uncertainty over timing and liabilities means investors are miles away from their destination.
Vedanta Zambia mess tarnishes Anglo breakup pitch 22 May 2019 President Edgar Lungu wants to nationalise the Indian firm’s Konkola copper mines. The hit looks manageable for owner Anil Agarwal. But falling out with a government is an eyesore, particularly if he wants investors to back a potential carve-up of Anglo American in South Africa.
Nestlé scrubs up well with private equity makeover 16 May 2019 Nordic buyout group EQT will pay $10 bln for the Swiss giant’s dermal filler and acne cream business. At that price the acquirer will need plump growth assumptions to make an acceptable return. The smart disposal should help boss Mark Schneider keep activist Dan Loeb at bay.
Private equity could choke on Imperial cigar sale 8 May 2019 Imperial Brands could raise 1 bln pounds from a unit that makes premium stogies. Its rapid growth means a buyout group could earn decent returns at that price. Yet concerns over cancer could irk their investors, and complicate an exit. A Chinese peer may be a more logical owner.
Europe’s $9 bln tower group offers clear 5G signal 7 May 2019 Mobile-mast specialist Cellnex should benefit from super-fast data networks even if telecom operators fail to recoup their heavy investments. Its latest 2.7 bln euro deal with France’s Iliad and a Swiss group, though, also shows fierce competition for infrastructure-like assets.
UniCredit’s spring clean would aid foreign jaunts 7 May 2019 Italy’s largest bank by assets is mulling a sale of its 2 bln euro stake in local online broker Fineco. Chunky capital gains on the holding would boost UniCredit’s solvency. That’s handy if it decides to make a swoop on in-play Commerzbank.
P&G could gain from shaving off Gillette 22 Apr 2019 The consumer giant’s razor business, which it bought for $57 bln back in 2005, has been blunted by cheaper competition. Sales, profit and market share are shrinking. A new owner might be able to lavish more attention on Gillette, and leave P&G to focus on areas like healthcare.